DK0719328T3 - Genet GRB 3-3, varianter deraf og anvendelse deraf - Google Patents

Genet GRB 3-3, varianter deraf og anvendelse deraf

Info

Publication number
DK0719328T3
DK0719328T3 DK94915598T DK94915598T DK0719328T3 DK 0719328 T3 DK0719328 T3 DK 0719328T3 DK 94915598 T DK94915598 T DK 94915598T DK 94915598 T DK94915598 T DK 94915598T DK 0719328 T3 DK0719328 T3 DK 0719328T3
Authority
DK
Denmark
Prior art keywords
variants
grb
genet
protein
sequences
Prior art date
Application number
DK94915598T
Other languages
Danish (da)
English (en)
Inventor
Fabien Schweighoffer
Bruno Tocque
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Application granted granted Critical
Publication of DK0719328T3 publication Critical patent/DK0719328T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475Growth factors; Growth regulators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702Regulators; Modulating activity
    • C07K14/4705Regulators; Modulating activity stimulating, promoting or activating activity
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • AIDS & HIV (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)
DK94915598T 1993-09-15 1994-05-09 Genet GRB 3-3, varianter deraf og anvendelse deraf DK0719328T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9310971A FR2710074B1 (fr) 1993-09-15 1993-09-15 Gène GRB3-3, ses variants et leurs utilisations.
PCT/FR1994/000542 WO1995007981A1 (fr) 1993-09-15 1994-05-09 Gene grb3-3, ses variants et leurs utilisations

Publications (1)

Publication Number Publication Date
DK0719328T3 true DK0719328T3 (da) 2000-11-13

Family

ID=9450882

Family Applications (1)

Application Number Title Priority Date Filing Date
DK94915598T DK0719328T3 (da) 1993-09-15 1994-05-09 Genet GRB 3-3, varianter deraf og anvendelse deraf

Country Status (27)

Country Link
US (2) US5831048A (sk)
EP (1) EP0719328B1 (sk)
JP (1) JP3794697B2 (sk)
KR (1) KR100330477B1 (sk)
CN (1) CN1098930C (sk)
AT (1) ATE196926T1 (sk)
AU (1) AU698819B2 (sk)
BR (1) BR9407693A (sk)
CA (1) CA2169938A1 (sk)
CZ (1) CZ288882B6 (sk)
DE (1) DE69426121T2 (sk)
DK (1) DK0719328T3 (sk)
ES (1) ES2152313T3 (sk)
FI (1) FI120499B (sk)
FR (1) FR2710074B1 (sk)
GR (1) GR3034600T3 (sk)
HU (1) HU221516B (sk)
IL (2) IL110942A (sk)
NO (1) NO319144B1 (sk)
NZ (1) NZ266162A (sk)
PL (1) PL178402B1 (sk)
PT (1) PT719328E (sk)
RU (1) RU2159815C2 (sk)
SK (1) SK281123B6 (sk)
UA (1) UA46715C2 (sk)
WO (1) WO1995007981A1 (sk)
ZA (1) ZA947059B (sk)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2732348B1 (fr) * 1995-03-31 1997-04-30 Rhone Poulenc Rorer Sa Systeme d'expression conditionnel
US6423824B1 (en) 1995-06-07 2002-07-23 Biogen, Inc. CAIP-like gene family
US5837844A (en) * 1995-06-07 1998-11-17 Biogen, Inc. CAIP-like gene family
US6171800B1 (en) 1995-06-07 2001-01-09 Biogen, Inc. Method of making and binding CAIP polypeptides
US5855911A (en) * 1995-08-29 1999-01-05 Board Of Regents, The University Of Texas System Liposomal phosphodiester, phosphorothioate, and P-ethoxy oligonucleotides
AU6342696A (en) * 1996-06-27 1998-01-14 Biogen, Inc. The caip-like gene family
US7309692B1 (en) 1996-07-08 2007-12-18 Board Of Regents, The University Of Texas System Inhibition of chronic myelogenous leukemic cell growth by liposomal-antisense oligodeoxy-nucleotides targeting to GRB2 or CRK1
US6977244B2 (en) * 1996-10-04 2005-12-20 Board Of Regents, The University Of Texas Systems Inhibition of Bcl-2 protein expression by liposomal antisense oligodeoxynucleotides
US7704962B1 (en) 1997-10-03 2010-04-27 Board Of Regents, The University Of Texas System Small oligonucleotides with anti-tumor activity
US7285288B1 (en) 1997-10-03 2007-10-23 Board Of Regents, The University Of Texas System Inhibition of Bcl-2 protein expression by liposomal antisense oligodeoxynucleotides
EP0998945A1 (en) * 1998-09-30 2000-05-10 Transgene S.A. Use of magnesium (Mg2+) for the enhancement of gene delivery in gene therapy
WO2001075164A2 (en) 2000-03-30 2001-10-11 Whitehead Institute For Biomedical Research Rna sequence-specific mediators of rna interference
DK2813582T3 (en) 2000-12-01 2017-07-31 Max-Planck-Gesellschaft Zur Förderung Der Wss E V Small RNA molecules that mediate RNA interference
EP1460898A4 (en) * 2002-01-03 2006-05-24 Univ Texas OLIGONUCLEOTIDES ANTISENSE WT1 INHIBITING BREAST CANCER

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2100860C (en) 1991-01-18 2003-11-25 Joseph Schlessinger A receptor tyrosine kinase target protein cdna cloning method and hgrb proteins
AU5136093A (en) * 1992-09-25 1994-04-26 Warner-Lambert Company Peptide antagonists of sh2 binding and therapeutic uses thereof

Also Published As

Publication number Publication date
FR2710074A1 (fr) 1995-03-24
DE69426121T2 (de) 2001-05-31
EP0719328B1 (fr) 2000-10-11
CN1133064A (zh) 1996-10-09
ES2152313T3 (es) 2001-02-01
AU698819B2 (en) 1998-11-05
IL110942A (en) 2001-12-23
USRE37952E1 (en) 2002-12-31
HU221516B (hu) 2002-11-28
RU2159815C2 (ru) 2000-11-27
PT719328E (pt) 2001-02-28
CN1098930C (zh) 2003-01-15
IL126756A (en) 2006-06-11
WO1995007981A1 (fr) 1995-03-23
JP3794697B2 (ja) 2006-07-05
NO960965D0 (no) 1996-03-08
NZ266162A (en) 1997-11-24
ATE196926T1 (de) 2000-10-15
IL110942A0 (en) 1994-11-28
FR2710074B1 (fr) 1995-12-08
KR100330477B1 (ko) 2002-12-02
JPH09502357A (ja) 1997-03-11
EP0719328A1 (fr) 1996-07-03
CZ75896A3 (en) 1996-06-12
US5831048A (en) 1998-11-03
BR9407693A (pt) 1997-02-04
SK281123B6 (sk) 2000-12-11
NO960965L (no) 1996-03-08
FI120499B (fi) 2009-11-13
PL313445A1 (en) 1996-07-08
CA2169938A1 (fr) 1995-03-23
SK34596A3 (en) 1996-07-03
PL178402B1 (pl) 2000-04-28
HUT74273A (en) 1996-11-28
FI961202A (fi) 1996-03-14
NO319144B1 (no) 2005-06-27
DE69426121D1 (de) 2000-11-16
HU9600668D0 (en) 1996-05-28
ZA947059B (en) 1995-05-18
CZ288882B6 (cs) 2001-09-12
GR3034600T3 (en) 2001-01-31
AU6724794A (en) 1995-04-03
UA46715C2 (uk) 2002-06-17
FI961202A0 (fi) 1996-03-14

Similar Documents

Publication Publication Date Title
FI962247A (fi) Uudet apoptoosia muuntavat proteiinit, niitä koodaava DNA ja näiden käyttömenetelmät
DK0719328T3 (da) Genet GRB 3-3, varianter deraf og anvendelse deraf
ES2105698T3 (es) Oligonucleotidos modificados con 7-deazapurina.
PT101297A (pt) Factores mitogenicos gliais, sua preparacao e utilizacao
DK2014678T3 (da) KDR-peptider og vacciner indeholdende disse
DK289688A (da) Ekspression af proapolipoprotein a-i.
DK0981630T3 (da) Polypeptider med prolyldipeptidylaminopeptidaseaktivitet og nukleinsyrer, der koder for samme
DK0640133T3 (da) Rekombinante DNA-molekyler, der koder for aminopeptidaseenzymer og deres anvendelse i fremstillingen af vacciner mod helmin
ATE384787T1 (de) Tripeptidyl-aminopeptidase
NO974035L (no) En ny vekstfaktor og en genetisk sekvens som koder for denne
EP1100815A4 (en) PROTEASE TYPE II CLEAVABLE PEPTIDE
HUP9904414A2 (hu) A neuritin neurogén
IL110392A0 (en) 9-n-bicyclic nucleoside agents useful as selective inhibitors of proinflammatory cytokines
DE69321720D1 (de) Für den interleukin-9-rezeptor kodierende nukleinsäuresequenzen bzw. dafür komplementäre nuleinsäuresequenzen
ATE215123T1 (de) Or-1, ein wais-rezeptor der nuklearen rezeptoren familie
DK1005532T3 (da) Isolerede nukleinsyremolekyler kodende for SSX familiemedlemmer og anvendelser deraf
DK0788549T3 (da) Regulerende nukleinsyresekvenser og anvendelser
IT1256078B (it) Ligandi kit solubili
SE9901115D0 (sv) Nucleotide sequences